Aqueous Compatible Fullerene-Doxorubicin Conjugates. - Wikidata - awgldk - TriplyDB

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

http://www.wikidata.org/entity/Q39747062

about

Core-Shell Silver/Polymeric Nanoparticles-Based Combinatorial Therapy against Breast Cancer In-vitro.Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C60 Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.Synthesis of PEGylated fullerene-5-fluorouracil conjugates to enhance the antitumor effect of 5-fluorouracil.Supramolecular Assembly of DNA on Graphene Nanoribbons.A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.C60 Fullerene Effects on Diphenyl-N-(trichloroacetyl)-amidophosphate Interaction with DNA In Silico and Its Cytotoxic Activity Against Human Leukemic Cell Line In Vitro.Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells.

P2860

Q37153729-7EE21F76-6EF0-4399-B649-AA5664E10599 Q37650538-0E0FB015-D37C-4C17-9F9C-9BE693B241DF Q37937579-FD8EC7A8-8A82-4E78-A98D-F0ACCA3CD5C4 Q39329841-19082FF0-68F0-44D7-AB1D-466C957F42F9 Q41807114-8750CAFB-FE8B-43F9-864F-8354F274B7F5 Q47147900-644C9AED-A168-45BB-A8CE-3162DF3D1560 Q47682144-DC25C31B-2042-4998-B590-D4277B709E0A Q52360925-D94B1BD0-18E7-4B5B-A7E5-4D8D02419AED Q55326759-90430340-E5E2-4869-B471-07375431598A

P2860

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

http://www.wikidata.org/entity/Q39747062

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@en

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@nl

type

label

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@en

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@nl

prefLabel

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@en

Aqueous Compatible Fullerene-Doxorubicin Conjugates.

@nl

P1433

Q39747062-7A07B402-1FBC-4332-9ED1-DD34FC227CDB

P1476

Q39747062-659C9210-FD3F-41B1-8AA8-16A8FBAC9E6C

P2093

Q39747062-08C3FF89-B1F9-4EBB-A180-BE37C04E4275

Q39747062-27ED5F6C-92F9-4CA5-9285-8C076E5EA817

Q39747062-58CCEC66-AF7F-463F-8B01-D99D4389E85A

Q39747062-6402A4E2-EB70-4DDE-9D8E-BCF1B6E508BC

Q39747062-74199A80-92DF-4671-8571-E0A7DEC5C3E0

Q39747062-C6A0554D-6194-40FF-B69D-D31ED3C1CF8E

Q39747062-E64BD06F-A114-4BC2-BFBA-A410A8304892

P2860

Q39747062-029BCA44-4607-4D09-BB9F-8F9C2C233BCF

Q39747062-1B931811-EF03-4C60-A99E-7FA480A5B7F6

Q39747062-1E25DF6D-DEA2-41F3-96AB-24E377820218

Q39747062-2544324F-9D0D-4970-934C-D193E324D553

Q39747062-3F1D2E40-C6C5-4782-BB0C-EB988CDA4A62

Q39747062-4223261F-3599-418C-899C-42275FD1CEF4

Q39747062-6210C418-060C-48C5-9837-587196320354

Q39747062-626A1E9D-6B43-4C26-ABB2-82BD7792E025

Q39747062-7D163603-FC71-4757-AF20-D15DD3A13C24

Q39747062-805E1FF9-5D8C-415E-85E5-ED8E2A7ED97E

P304

Q39747062-277AAE52-A212-4BA4-A412-03D4AEB2A36A

P31

Q39747062-21492D1E-403A-4E00-A000-935F8C74B5AF

P356

Q39747062-B9033E2F-0557-4062-8593-3049A10CBEF6

P433

Q39747062-9C9925CE-3A67-4A26-9B70-E533E267B94A

P478

Q39747062-FFE9702A-2B90-451D-A101-D4D9E04E1011

P50

Q39747062-B924FE7E-6B78-4CE7-BF03-F036C92EBF15

Q39747062-F11D5284-5BF6-4788-982B-A10EED185AEB

P577

Q39747062-4288CC5A-0048-449C-8F83-55D7DCD39E8D

P5875

Q39747062-CAD44A08-C897-4731-8A9B-806F4A9410DC

P698

Q39747062-886C2F18-038C-41E8-8AF7-342C3976D159

P921

Q39747062-34033F09-A5AB-49CD-A990-3085201891BD

P932

Q39747062-2A915F47-6C90-47E0-A5B6-F85098AB37B5

P356

P1433

Journal of Physical Chemistry C

P1476

Aqueous Compatible Fullerene-Doxorubicin Conjugates

@en

P2093

Alex Kitaygorodskiy

http://www.w3.org/2001/XMLSchema#string

Huaping Li

http://www.w3.org/2001/XMLSchema#string

Lingrong Gu

http://www.w3.org/2001/XMLSchema#string

Pengju G Luo

http://www.w3.org/2001/XMLSchema#string

Sebastian Lacher

http://www.w3.org/2001/XMLSchema#string

Sk Anwarul Haque

http://www.w3.org/2001/XMLSchema#string

Ya-Ping Sun

http://www.w3.org/2001/XMLSchema#string

P2860

C60-Fullerene monomalonate adducts selectively inactivate neuronal nitric oxide synthase by uncoupling the formation of reactive oxygen intermediates from nitric oxide production.

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

Carboxyfullerenes as neuroprotective agents.

Adriamycin. A new anticancer drug with significant clinical activity.

Fullerene derivatives: an attractive tool for biological applications.

Recent advances in protection against doxorubicin-induced toxicity.

Fullerene for organic electronics.

Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas.

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.

Active nanodiamond hydrogels for chemotherapeutic delivery.

P304

17768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JP906750Z

http://www.w3.org/2001/XMLSchema#string

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41166629

http://www.w3.org/2001/XMLSchema#string

P698

20107626

http://www.w3.org/2001/XMLSchema#string

P921

P932

2811372

http://www.w3.org/2001/XMLSchema#string